動物用腫瘍学市場：治療法、動物タイプ、がんタイプ別-2025-2030年の世界予測

動物用腫瘍学市場の2023年の市場規模は3億9,030万米ドルで、2024年には4億2,972万米ドルに達すると予測され、CAGR 10.24％で成長し、2030年には7億7,277万米ドルに達すると予測されています。

動物用腫瘍学市場は、ニッチではあるが急速に発展している分野であり、動物のがんの診断と治療に焦点を当てています。この分野は、特にペットの飼育率や動物ヘルスケアへの支出が高い先進地域において、ペットのがんの有病率が上昇しているため、獣医学的ケアの重要な側面となりつつあります。動物用腫瘍学の必要性は、ペットの飼い主がペットの生活の質と寿命を延ばすことに感情的・経済的価値を置き、高度な治療と診断の需要を煽っていることにあります。動物用腫瘍学の治療用途には、化学療法、放射線療法、免疫療法、外科的介入などがあり、最終用途は動物病院、クリニック、動物専門のがん治療センターなど多岐にわたります。

市場成長は、獣医学的診断における継続的な進歩、ペットがんの発生率の上昇、利用可能な治療オプションに関する飼い主の意識の高まりに大きく影響されています。動物用医薬品と生物製剤の技術革新は、標的療法と個別化医療アプローチによって治療プロトコルの強化に道を開くという重要な役割を果たしています。最も有望な機会のひとつは、早期発見とより良い予後予測ツールのためのAIと機械学習技術の統合と同様に、より手頃な価格で利用しやすい治療オプションの開発にあります。しかし、高額な治療費、限られた保険適用範囲、ペットの飼い主の精神的負担といった課題は、市場拡大の妨げとなる可能性があります。

さらに、動物用腫瘍学インフラの地理的制限や、より専門的な獣医腫瘍医の必要性が潜在的な障壁を強調しています。成長機会を活用するために、企業は低コストで効果の高い代替治療を目指した研究開発イニシアチブに注力し、診断能力を強化するためにハイテク企業との提携を模索すべきです。より精密で効果的な治療法を開発するためのバイオテクノロジーの進歩やゲノム研究など、革新的な分野を探る価値があります。動物用腫瘍学市場の性質は高度に専門化され、急速に成長しているため、事業成長を維持するためには、技術の進歩や消費者の期待の変化への継続的な適応が求められます。

市場力学：急速に進化する動物用腫瘍学市場の主要市場インサイトを公開

動物用腫瘍学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ペット動物におけるがんの有病率の増加
  • がん管理のための研究開発イニシアチブの高まり
  • ペット治療における技術の進歩
• 市場抑制要因
  • ペットのがん治療コストの高さ
• 市場機会
  • 獣医がん治療に関する意識の高まり
  • 政府の積極的な取り組み
• 市場の課題
  • ペットのがん治療に使用される薬剤の副作用

ポーターの5つの力：動物用腫瘍学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用腫瘍学市場における外部からの影響の把握

外部マクロ環境要因は、動物用腫瘍学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用腫瘍学市場における競合情勢の把握

動物用腫瘍学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用腫瘍学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用腫瘍学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用腫瘍学市場における成功への道筋を描く

動物用腫瘍学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペット動物におけるがんの罹患率の増加
    • がん治療のための研究開発の取り組みの拡大
    • ペット治療における技術の進歩
  • 抑制要因
    • ペットのがん治療の高額な費用
  • 機会
    • 獣医がん治療に関する意識の高まり
    • 政府の好ましい取り組み
  • 課題
    • ペットのがん治療に使用される薬剤の副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用腫瘍学市場セラピー

• 化学療法
• 免疫療法
• 放射線科
• 手術

第7章 動物用腫瘍学市場動物の種類別

• 犬
• ネコ科

第8章 動物用腫瘍学市場がんの種類別

• リンパ腫
• 乳腺がんおよび扁平上皮がん
• 肥満細胞がん

第9章 南北アメリカの動物用腫瘍学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の動物用腫瘍学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの動物用腫瘍学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AB Science SA
• Anivive Lifesciences
• Ardent Animal Health, LLC
• C.H. Boehringer Sohn AG & Ko. KG
• Ceva Sante Animale S.A.
• Covetrus, Inc.
• Elanco Animal Health Incorporated
• ELIAS Animal Health
• Fidocure
• IDEXX Laboratories, Inc.
• Karyopharm Therapeutics Inc.
• Leroy Biotech S.A.S.
• Morphogenesis, Inc.
• Nippon Zenyaku Kogyo Co., Ltd.
• PetCure Oncology LLC
• PharmAust Limited
• Regeneus Ltd.
• Rhizen Pharmaceuticals AG
• Torigen Pharmaceuticals Inc.
• Varian Medical Systems, Inc.
• Vetco Pharmaceuticals Inc.
• VetDC, Inc.
• Vetoquinol S.A.
• Virbac SA
• VolitionRx Limited
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY ONCOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY ONCOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 146. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Oncology Market was valued at USD 390.30 million in 2023, expected to reach USD 429.72 million in 2024, and is projected to grow at a CAGR of 10.24%, to USD 772.77 million by 2030.

The veterinary oncology market is a niche but rapidly evolving segment, focusing on the diagnosis and treatment of cancer in animals. This field is increasingly becoming a critical aspect of veterinary care due to the rising prevalence of cancer among pets, notably in developed regions where pet ownership and animal healthcare spending are high. The necessity of veterinary oncology lies in the emotional and financial value pet owners place on extending the quality and longevity of their pets' lives, fueling demand for advanced treatments and diagnostics. Applications of veterinary oncology include chemotherapy, radiation therapy, immunotherapy, and surgical interventions, with numerous end-use scope extending to veterinary clinics, hospitals, and specialized cancer treatment centers for animals.

Market growth is significantly influenced by the continuous advancements in veterinary diagnostics, the rising incidence of pet cancer, and the increasing awareness among pet owners about available treatment options. Innovations in veterinary pharmaceuticals and biologics play a crucial role, with targeted therapies and personalized medical approaches paving the way for enhanced treatment protocols. One of the most promising opportunities lies in the development of more affordable and accessible treatment options, as well as the integration of AI and machine learning technologies for early detection and better prognostic tools. However, challenges such as the high cost of treatments, limited insurance coverage, and the emotional burden on pet owners can impede market expansion.

Furthermore, geographical limitations in veterinary oncology infrastructure and the need for more specialized veterinary oncologists underscore potential barriers. To leverage growth opportunities, businesses should focus on R&D initiatives aimed at low-cost, high-efficacy treatment alternatives and explore partnerships with tech companies to enhance diagnostic capabilities. Innovation areas worth exploring include biotechnological advancements and genomic studies to develop more precise and effective therapies. The nature of the veterinary oncology market is highly specialized and rapidly growing, demanding continuous adaptation to technological advancements and changing consumer expectations to sustain business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Oncology Market

The Veterinary Oncology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Cancer in Pet Animals
  • Growing R&D Initiatives for Cancer Management
  • Technological Advancement in Pet Treatment
• Market Restraints
  • High Cost of Pet Cancer Treatment
• Market Opportunities
  • Rising Awareness Regarding Veterinary Cancer Therapies
  • Favourable Government Initiatives
• Market Challenges
  • Adverse Effect of Drugs used for Pet Cancer Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Oncology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Oncology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Oncology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Oncology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Oncology Market

A detailed market share analysis in the Veterinary Oncology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Oncology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Oncology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Oncology Market

A strategic analysis of the Veterinary Oncology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Oncology Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, Anivive Lifesciences, Ardent Animal Health, LLC, C.H. Boehringer Sohn AG & Ko. KG, Ceva Sante Animale S.A., Covetrus, Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories, Inc., Karyopharm Therapeutics Inc., Leroy Biotech S.A.S., Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., PetCure Oncology LLC, PharmAust Limited, Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems, Inc., Vetco Pharmaceuticals Inc., VetDC, Inc., Vetoquinol S.A., Virbac SA, VolitionRx Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapy, market is studied across Chemotherapy, Immunotherapy, Radiology, and Surgery.
• Based on Animal Type, market is studied across Canine and Feline.
• Based on Cancer Type, market is studied across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
    • 5.1.1.2. Growing R&D Initiatives for Cancer Management
    • 5.1.1.3. Technological Advancement in Pet Treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Pet Cancer Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
    • 5.1.3.2. Favourable Government Initiatives
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Oncology Market, by Therapy

• 6.1. Introduction
• 6.2. Chemotherapy
• 6.3. Immunotherapy
• 6.4. Radiology
• 6.5. Surgery

7. Veterinary Oncology Market, by Animal Type

• 7.1. Introduction
• 7.2. Canine
• 7.3. Feline

8. Veterinary Oncology Market, by Cancer Type

• 8.1. Introduction
• 8.2. Lymphoma
• 8.3. Mammary and Squamous Cell Cancer
• 8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Oncology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Oncology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AB Science SA
• 2. Anivive Lifesciences
• 3. Ardent Animal Health, LLC
• 4. C.H. Boehringer Sohn AG & Ko. KG
• 5. Ceva Sante Animale S.A.
• 6. Covetrus, Inc.
• 7. Elanco Animal Health Incorporated
• 8. ELIAS Animal Health
• 9. Fidocure
• 10. IDEXX Laboratories, Inc.
• 11. Karyopharm Therapeutics Inc.
• 12. Leroy Biotech S.A.S.
• 13. Morphogenesis, Inc.
• 14. Nippon Zenyaku Kogyo Co., Ltd.
• 15. PetCure Oncology LLC
• 16. PharmAust Limited
• 17. Regeneus Ltd.
• 18. Rhizen Pharmaceuticals AG
• 19. Torigen Pharmaceuticals Inc.
• 20. Varian Medical Systems, Inc.
• 21. Vetco Pharmaceuticals Inc.
• 22. VetDC, Inc.
• 23. Vetoquinol S.A.
• 24. Virbac SA
• 25. VolitionRx Limited
• 26. Zoetis Inc.